Barinthus Biotherapeutics plc.(BRNS)— Stock Profile, AI Score & Financials

Healthcare · Nasdaq · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated .

Barinthus Biotherapeutics plc. (BRNS) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. BRNS is not currently included in 13F Pro's AI-ranked quality universe — quality rankings require at least 50 unique 13-f institutional holders to ensure peer comparisons are meaningful. only 15 institutional filers currently hold this stock. Based on the latest XBRL financial filings (Q2 2026), Barinthus Biotherapeutics plc. reports net income of $-10.6M, free cash flow of $-8.1M. Top institutional holders of BRNS by reported 13-F value include M&G Plc, SC CHINA HOLDING Ltd, GLR Partners, based on the most recent SEC filings. BRNS trades on the Nasdaq exchange and files with the SEC under CIK 1828185. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate BRNS daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Barinthus Biotherapeutics plc. directly from SEC EDGAR.

Net Income

$-10.6M

Free Cash Flow

$-8.1M

BRNS key financials by period

Barinthus Biotherapeutics plc. reported revenue, net income and margins by fiscal period, from SEC filings.
PeriodFormRevenueNet incomeOperating margin
FY 202410-K$15.0M$-61.1M—
FY 202310-K$802.0K$-73.3M—
FY 202210-K$44.7M$5.3M-9.0%
FY 202110-K$268.0K$-50.9M—
FY 202010-K$4.8M$-17.7M—

Institutions holding BRNS

Institutional investors reporting a position in Barinthus Biotherapeutics plc. on SEC Form 13F.
InstitutionSharesValueReported
M&G Plc5,197,349$5.2M2026-06-30
SC CHINA HOLDING Ltd1,420,473$937.5K2026-06-30
GLR Partners1,243,377$820.6K2026-06-30
DC Funds642,204$423.9K2026-06-30
Rangeley Capital185,136$122.2K2026-06-30
Johns Hopkins University122,237$80.7K2026-06-30
MORGAN STANLEY108,843$71.8K2026-06-30
Baird Financial Group105,961$69.9K2026-06-30
CITADEL ADVISORS76,754$50.7K2026-06-30
HighTower Advisors37,450$24.7K2026-06-30
SEC EDGAR: CIK 1828185 →
BRNS

Barinthus Biotherapeutics plc.

BRNS
NasdaqSmall CapHealthcare

13F Pro Quality Score

Not in ranked universe

Limited institutional coverage

Quality rankings require at least 50 unique 13-F institutional holders to ensure peer comparisons are meaningful. Only 15 institutional filers currently hold this stock.

Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.

Price Chart

Email me the moment this company reports earnings
AI Research Report
Two-page plain-English analysis: business, thesis, and three scenarios for the next two years. Refreshed every quarter.
Upgrade to Pro
Pro: 5 reports/month · Pro+: unlimitedOpinion, not investment advice. Do your own research.
Reading the latest SEC filing… (first load can take ~20s)

Key Metrics

Net Income

Q2 2026
EDGAR

$-10.58M

EPS (Diluted)

Q2 2026
EDGAR

$-0.26

Free Cash Flow

Q2 2026
EDGAR

$-8.09M

Top Institutional Holders

as of Q2 2026
$7.84M total
M&G Plc
$5.20M0.0%
SC CHINA HOLDING Ltd
$937.5K0.0%
GLR Partners, LLC
$820.6K0.0%
DC Funds, LP
$423.9K0.0%
Rangeley Capital, LLC
$122.2K+16.1%
Johns Hopkins University
$80.7K0.0%
MORGAN STANLEY
$71.8K+4825.0%
Baird Financial Group, Inc.
$69.9K0.0%
CITADEL ADVISORS LLC
$50.7K-35.5%
HighTower Advisors, LLC
$24.7K0.0%

Financial Trends

Revenue & Net Income

Earnings Per Share

Loading ratio trend…